Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Cancer Res. 2019 Jul 10;79(17):4360–4370. doi: 10.1158/0008-5472.CAN-18-3525

Figure 6.

Figure 6.

Validation of the changes in expression of stemness genes caused by metformin in HNSCC cells. A. Validation of the stemness genes (SOX2/ALDH1A1/BMI1/CD44/CD133) expression in the indicated HNSCC cells treated with or without metformin in vitro, measured by qPCR. (*, P<0.05; **, P<0.01; ***, P<0.001; mean ± SD.) B. The cell lysates were used to evaluate the expression of the protein product of stemness genes in response to metformin and the impact of methyl-pyruvate treatment as in A.